Insider Transactions in Q4 2025 at Turn Therapeutics Inc. (TTRX)
Insider Transaction List (Q4 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 12
2025
|
Zuraiz Chaudhary Officer |
BUY
Open market or private purchase
|
Direct |
2,500
+16.67%
|
$7,500
$3.5 P/Share
|
|
Nov 24
2025
|
Arthur F Golden Director |
BUY
Open market or private purchase
|
Direct |
9,868
+14.0%
|
$29,604
$3.44 P/Share
|
|
Nov 21
2025
|
Arthur F Golden Director |
BUY
Open market or private purchase
|
Direct |
20,532
+28.81%
|
$41,064
$2.87 P/Share
|
|
Nov 21
2025
|
Zuraiz Chaudhary Officer |
BUY
Open market or private purchase
|
Direct |
1,000
+9.09%
|
$3,000
$3.29 P/Share
|
|
Nov 20
2025
|
Zuraiz Chaudhary Officer |
BUY
Open market or private purchase
|
Direct |
1,450
+13.88%
|
$2,900
$2.61 P/Share
|
|
Nov 17
2025
|
Zuraiz Chaudhary Officer |
BUY
Open market or private purchase
|
Direct |
2,500
+24.88%
|
$7,500
$3.62 P/Share
|
|
Oct 23
2025
|
Abraham Chesed |
BUY
Open market or private purchase
|
Indirect |
14,286
+0.98%
|
$57,144
$4.6 P/Share
|
|
Oct 23
2025
|
Arthur F Golden Director |
BUY
Open market or private purchase
|
Direct |
20,202
+40.08%
|
$80,808
$4.95 P/Share
|
|
Oct 23
2025
|
Zuraiz Chaudhary Officer |
BUY
Open market or private purchase
|
Direct |
5,050
+50.0%
|
$20,200
$4.95 P/Share
|
|
Oct 08
2025
|
Andrew Gengos Director |
BUY
Grant, award, or other acquisition
|
Direct |
10,000
+50.0%
|
-
|
|
Oct 08
2025
|
Arthur F Golden Director |
BUY
Grant, award, or other acquisition
|
Direct |
10,000
+50.0%
|
-
|
|
Oct 08
2025
|
Kent Edward Kester Director |
BUY
Grant, award, or other acquisition
|
Direct |
10,000
+50.0%
|
-
|
|
Oct 08
2025
|
Neilesh Shailesh Ghodadra Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
10,000
+50.0%
|
-
|